Spotlight on VSL#3 Probiotic Mixture in Chronic Inflammatory Bowel Diseases

Author： Chapman Therese M.   Plosker Greg L.   Figgitt David P.  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.21, Iss.1, 2007-01, pp. : 61-63

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Les nouvelles cibles thérapeutiques des maladies inflammatoires chroniques de l’intestin: New Therapeutic Targets in Chronic Inflammatory Bowel Diseases

By Cortot Antoine  

Therapie, Vol. 59, Iss. 1, 2004-01 ,pp. : 77-81

Adis International

Access to resources Recommend Favorite

Probiotics and Inflammatory Bowel Disease

By Kwon J.H.   Farrell R.J.  

BioDrugs, Vol. 17, Iss. 3, 2003-01 ,pp. : 179-186

Adis International

Access to resources Recommend Favorite

Spotlight on Imatinib Mesylate in Chronic Myeloid Leukemia

By Curran M.P.   Croom K.F.   Goa K.L.  

BioDrugs, Vol. 18, Iss. 3, 2004-01 ,pp. : 207-210

Adis International

Access to resources Recommend Favorite

Tolerability of Aminosalicylates in Inflammatory Bowel Disease

By Ishaq S.  

BioDrugs, Vol. 15, Iss. 5, 2001-05 ,pp. : 339-349

Adis International

Access to resources Recommend Favorite

Polymorphisme génétique et traitement des maladies inflammatoires chroniques de l’intestin : exemple de l’azathioprine: Genetic Polymorphism Biotransformation of Azathioprine and Treatment of Inflammatory Bowel Diseases

By Bessard Germain   Hardy Gaëlle   Chartier Alain   Stanke-Labesque Françoise  

Therapie, Vol. 59, Iss. 1, 2004-01 ,pp. : 71-75

Adis International

Access to resources Recommend Favorite